Correlation Between Fate Therapeutics and Boundless Bio,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Boundless Bio, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Boundless Bio, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and Boundless Bio, Common, you can compare the effects of market volatilities on Fate Therapeutics and Boundless Bio, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Boundless Bio,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Boundless Bio,.

Diversification Opportunities for Fate Therapeutics and Boundless Bio,

0.56
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Fate and Boundless is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Boundless Bio, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Boundless Bio, Common and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Boundless Bio,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Boundless Bio, Common has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Boundless Bio, go up and down completely randomly.

Pair Corralation between Fate Therapeutics and Boundless Bio,

Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the Boundless Bio,. In addition to that, Fate Therapeutics is 1.29 times more volatile than Boundless Bio, Common. It trades about -0.14 of its total potential returns per unit of risk. Boundless Bio, Common is currently generating about -0.07 per unit of volatility. If you would invest  352.00  in Boundless Bio, Common on September 26, 2024 and sell it today you would lose (96.00) from holding Boundless Bio, Common or give up 27.27% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Fate Therapeutics  vs.  Boundless Bio, Common

 Performance 
       Timeline  
Fate Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Boundless Bio, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Boundless Bio, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Fate Therapeutics and Boundless Bio, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fate Therapeutics and Boundless Bio,

The main advantage of trading using opposite Fate Therapeutics and Boundless Bio, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Boundless Bio, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boundless Bio, will offset losses from the drop in Boundless Bio,'s long position.
The idea behind Fate Therapeutics and Boundless Bio, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum